Tag: GARDP

Live webinar – GARDP and JPIAMR collaboration

Anders BjersNews and press

GARDP is organising a live webinar on October 8th on the topic “Exploring safety issues in antimicrobial drug development”.

GARDP is organising a live webinar on October 8th: Exploring safety issues in antimicrobial drug development.

This webinar was developed in collaboration with CARB-X, JPIAMR, REPAIR Impact Fund, Wellcome Trust, ASM and ESCMID. It is part of the ‘Antibiotic Bootcamps for Developers’ series which have been developed by GARDP and its partners at the ‘ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance’ since 2017. As this years’ conference could not be held, the content was developed under the umbrella of the REVIVE webinar series.

Read more and register.

JPIAMR Highlighted in G20 Health Ministers Joint Declaration

Anders BjersNews and press

The 2018 G20 Health Ministerial Meeting in Mar del Plata, Argentina, concluded on October 4th with a joint declaration on concrete health policy proposals.

The document considers health a key aspect for sustainable development and calls for a further strengthening health systems. It also recommends concrete actions to address global issues such as antimicrobial resistance, and with commitments for “increasing the level of awareness on the prudent and responsible use and disposal of antibiotics of all healthcare providers, veterinarians, farmers and food producers and of the general public.”

In the declaration, the G20 also mentions JPIAMR together with GARDP, UNITAD, CARB-X and the TB-Alliance, welcoming the work of these leading international initiatives.

Please view the full declaration here.

AMR in focus at G 7 Health Ministers meeting in Milan

Anders BjersNews and press

On November 5 and 6, the G7 Ministerial Meeting on Health took place in Milan, Italy. On the agenda for the second day was antimicrobial resistance (AMR). The discussions focused on crucial topics of global health. The aim of the meeting was among else to coordinate global and concrete actions. In that context, participating Health Ministers expressed that they welcome the establishment of the Global AMR R&D Hub and call to ensure it becomes an effective platform to align and increase global investment in much needed R&D based on WHO recommendations, e.g. the Priority Pathogen List (PPL).  They expressed support for the collaboration of the Global AMR R&D Hub with existing international networks and initiatives like the Interagency Coordination Group on AMR, the Global Antibiotic Research & Development Partnership (GARDP), CARB-X and the Joint Programming Initiative on AMR (JPIAMR). G7 Health Ministers expressed support for the development of evidence-based strategies, tools and interventions to fight AMR, and sustain research related to the Strategic Objectives of the WHO Global Action Plan. As well as to promote R&D for new antimicrobials, alternative therapies, vaccines and rapid-point-of care diagnostics, in particular for WHO-defined priority pathogens and tuberculosis.

JPIAMR welcomes the G7 Health Ministers focus on global coordination, supported R&D areas and the many dimensions of Antibiotic Resistance, the impacts are real now. The actions of JPIAMRs 26 member nations concerted efforts to meet human needs- and scientific results are tangible today. JPIAMR has merged the shared Strategic Research Agenda with a One Health approach. A crucial component and strategy since antimicrobial resistance do not adhere to any boundaries. In 2018 JPIAMR launches it´s 6th call: Innovation against antibiotic resistant bacteria – New targets, compounds and tools. This as a direct response to the WHO Priority Pathogens List (PPL). Coordinating participating nations resources for funding research that targets the 12 groups of bacteria and drug-resistant tuberculosis listed by WHO.

JPIAMR also welcome the initiative of the Global AMR R&D Hub, working side by side to ensure that innovation is in focus and not duplication. Seeing that a diverse range of research and resources can match and harness AMR as the multidimensional global threat it is.

Working together makes the difference we need – to harness AMR in time.